Literature DB >> 32024765

Cancer Progress and Priorities: Prostate Cancer.

Kevin H Kensler1, Timothy R Rebbeck2.   

Abstract

Entities:  

Year:  2020        PMID： 32024765      PMCID： PMC7006991          DOI： 10.1158/1055-9965.EPI-19-0412

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  168 in total

1.  The Association Between Vasectomy and Prostate Cancer: A Systematic Review and Meta-analysis.

Authors:  Bimal Bhindi; Christopher J D Wallis; Madhur Nayan; Ann M Farrell; Landon W Trost; Robert J Hamilton; Girish S Kulkarni; Antonio Finelli; Neil E Fleshner; Stephen A Boorjian; R Jeffrey Karnes
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

2.  Alcohol intake, drinking patterns, and prostate cancer risk and mortality: a 30-year prospective cohort study of Finnish twins.

Authors:  Barbra A Dickerman; Sarah Coseo Markt; Markku Koskenvuo; Eero Pukkala; Lorelei A Mucci; Jaakko Kaprio
Journal:  Cancer Causes Control       Date:  2016-06-28       Impact factor: 2.506

3.  Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.

Authors:  Michael W Drazer; Dezheng Huo; Mara A Schonberg; Aria Razmaria; Scott E Eggener
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

Review 4.  American Cancer Society guideline for the early detection of prostate cancer: update 2010.

Authors:  Andrew M D Wolf; Richard C Wender; Ruth B Etzioni; Ian M Thompson; Anthony V D'Amico; Robert J Volk; Durado D Brooks; Chiranjeev Dash; Idris Guessous; Kimberly Andrews; Carol DeSantis; Robert A Smith
Journal:  CA Cancer J Clin       Date:  2010-03-03       Impact factor: 508.702

5.  Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.

Authors:  Richard M Martin; Jenny L Donovan; Emma L Turner; Chris Metcalfe; Grace J Young; Eleanor I Walsh; J Athene Lane; Sian Noble; Steven E Oliver; Simon Evans; Jonathan A C Sterne; Peter Holding; Yoav Ben-Shlomo; Peter Brindle; Naomi J Williams; Elizabeth M Hill; Siaw Yein Ng; Jessica Toole; Marta K Tazewell; Laura J Hughes; Charlotte F Davies; Joanna C Thorn; Elizabeth Down; George Davey Smith; David E Neal; Freddie C Hamdy
Journal:  JAMA       Date:  2018-03-06       Impact factor: 56.272

6.  Validation of genome-wide prostate cancer associations in men of African descent.

Authors:  Bao-Li Chang; Elaine Spangler; Stephen Gallagher; Christopher A Haiman; Brian Henderson; William Isaacs; Marnita L Benford; LaCreis R Kidd; Kathleen Cooney; Sara Strom; Sue Ann Ingles; Mariana C Stern; Roman Corral; Amit D Joshi; Jianfeng Xu; Veda N Giri; Benjamin Rybicki; Christine Neslund-Dudas; Adam S Kibel; Ian M Thompson; Robin J Leach; Elaine A Ostrander; Janet L Stanford; John Witte; Graham Casey; Rosalind Eeles; Ann W Hsing; Stephen Chanock; Jennifer J Hu; Esther M John; Jong Park; Klara Stefflova; Charnita Zeigler-Johnson; Timothy R Rebbeck
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-11-11       Impact factor: 4.254

Review 7.  Is alcohol consumption a risk factor for prostate cancer? A systematic review and meta-analysis.

Authors:  Jinhui Zhao; Tim Stockwell; Audra Roemer; Tanya Chikritzhs
Journal:  BMC Cancer       Date:  2016-11-15       Impact factor: 4.430

Review 8.  The association between Selenium and Prostate Cancer: a Systematic Review and Meta-Analysis

Authors:  Kourosh Sayehmiri; Milad Azami; Younes Mohammadi; Ali Soleymani; Zainab Tardeh
Journal:  Asian Pac J Cancer Prev       Date:  2018-06-25

9.  Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Authors:  Alex Tsodikov; Roman Gulati; Eveline A M Heijnsdijk; Paul F Pinsky; Sue M Moss; Sheng Qiu; Tiago M de Carvalho; Jonas Hugosson; Christine D Berg; Anssi Auvinen; Gerald L Andriole; Monique J Roobol; E David Crawford; Vera Nelen; Maciej Kwiatkowski; Marco Zappa; Marcos Luján; Arnauld Villers; Eric J Feuer; Harry J de Koning; Angela B Mariotto; Ruth Etzioni
Journal:  Ann Intern Med       Date:  2017-09-05       Impact factor: 25.391

10.  Diabetes, prostate cancer screening and risk of low- and high-grade prostate cancer: an 11 year historical population follow-up study of more than 1 million men.

Authors:  Rachel Dankner; Paolo Boffetta; Lital Keinan-Boker; Ran D Balicer; Alla Berlin; Liraz Olmer; Havi Murad; Barbara Silverman; Moshe Hoshen; Laurence S Freedman
Journal:  Diabetologia       Date:  2016-05-17       Impact factor: 10.122
View more
  5 in total

1.  Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer.

Authors:  Maud de Dieuleveult; Claire Marchal; Anne Jouinot; Anne Letessier; Benoit Miotto
Journal:  Cancers (Basel)       Date:  2020-04-29       Impact factor: 6.639

2.  A Small Peptide Targeting the Ligand-Induced Androgen Receptor/Filamin a Interaction Inhibits the Invasive Phenotype of Prostate Cancer Cells.

Authors:  Marzia Di Donato; Pia Giovannelli; Maria Vittoria Barone; Ferdinando Auricchio; Gabriella Castoria; Antimo Migliaccio
Journal:  Cells       Date:  2021-12-22       Impact factor: 6.600

3.  Testing the generalizability of ancestry-specific polygenic risk scores to predict prostate cancer in sub-Saharan Africa.

Authors:  Michelle S Kim; Daphne Naidoo; Ujani Hazra; Melanie H Quiver; Wenlong C Chen; Corinne N Simonti; Paidamoyo Kachambwa; Maxine Harlemon; Ilir Agalliu; Shakuntala Baichoo; Pedro Fernandez; Ann W Hsing; Mohamed Jalloh; Serigne M Gueye; Lamine Niang; Halimatou Diop; Medina Ndoye; Nana Yaa Snyper; Ben Adusei; James E Mensah; Afua O D Abrahams; Richard Biritwum; Andrew A Adjei; Akindele O Adebiyi; Olayiwola Shittu; Olufemi Ogunbiyi; Sikiru Adebayo; Oseremen I Aisuodionoe-Shadrach; Maxwell M Nwegbu; Hafees O Ajibola; Olabode P Oluwole; Mustapha A Jamda; Elvira Singh; Audrey Pentz; Maureen Joffe; Burcu F Darst; David V Conti; Christopher A Haiman; Petrus V Spies; André van der Merwe; Thomas E Rohan; Judith Jacobson; Alfred I Neugut; Jo McBride; Caroline Andrews; Lindsay N Petersen; Timothy R Rebbeck; Joseph Lachance
Journal:  Genome Biol       Date:  2022-09-13       Impact factor: 17.906

4.  CircSMARCC1 facilitates tumor progression by disrupting the crosstalk between prostate cancer cells and tumor-associated macrophages via miR-1322/CCL20/CCR6 signaling.

Authors:  Tao Xie; Du-Jiang Fu; Zhi-Min Li; Dao-Jun Lv; Xian-Lu Song; Yu-Zhong Yu; Chong Wang; Kang-Jin Li; Baoqian Zhai; Jiacheng Wu; Ning-Han Feng; Shan-Chao Zhao
Journal:  Mol Cancer       Date:  2022-09-01       Impact factor: 41.444

Review 5.  The Etiology and Pathophysiology Genesis of Benign Prostatic Hyperplasia and Prostate Cancer: A New Perspective.

Authors:  Teow J Phua
Journal:  Medicines (Basel)       Date:  2021-06-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.